GOLPH3 and gastric cancer: The serum GOLPH3 concentration was 6.49 (5.61-7.90) ng/mL in GC patients and 7.67 (5.51-12.75) ng/mL in CRC patients, significantly higher than the 2.78 (2.25-4.12) ng/mL in healthy controls (P < 0.001) (Table 1 and Figure 2).